This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
A promising new drug to combat serious inflammatory disease
Read more
Biosimilar infliximab comparable to reference product and adalimumab in real-world study
Read more
New data demonstrates long-term skin clearance in patients treated with guselkumab
Read more
Rare medullary thyroid cancer treatment gets nod from NICE
Read more
New England Journal of Medicine publishes nusinersen Phase III CHERISH study results
Read more
Cancer Research UK to invest £45 million in clinical trials
Read more
Celltrion’s biosimilar trastuzumab approved in Europe
Read more
Radiometer helps enhance patient outcomes at the University of Leicester Hospitals NHS Trust
Read more
NICE approval for differentiated thyroid cancer drug
Read more
NICE Final Appraisal Determination recommends use of brodalumab as cost-effective
Read more
Page 85 of 352
« First
«
...
10
20
30
...
83
84
85
86
87
...
90
100
110
...
»
Last »
Popular articles
Unravelling the origins of second cancers in children with Dr Jaume Mora
13 May, 2024
Tafamidis now available on the NHS as first approved treatment for ATTR-CM
16 May, 2024
Even light physical activity can mitigate ‘ticking time bomb’ of cardiac health, study finds
16 May, 2024
x
Search for: